INCREASED ENDOTHELIN-1 AND ITS LOCALIZATION DURING THE DEVELOPMENT OFBLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS

Citation
Se. Mutsaers et al., INCREASED ENDOTHELIN-1 AND ITS LOCALIZATION DURING THE DEVELOPMENT OFBLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS, American journal of respiratory cell and molecular biology, 18(5), 1998, pp. 611-619
Citations number
53
Categorie Soggetti
Cell Biology",Biology,"Respiratory System
ISSN journal
10441549
Volume
18
Issue
5
Year of publication
1998
Pages
611 - 619
Database
ISI
SICI code
1044-1549(1998)18:5<611:IEAILD>2.0.ZU;2-7
Abstract
Endothelin-1 (Et-1) has been implicated in the pathogenesis of pulmona ry fibrosis with increased levels in the lung tissue of patients with pulmonary fibrosis and profibrotic effects in vitro. In this study we have investigated the temporal changes in lung Et-1 levels and immunoh istochemical localization in relation to collagen deposition during th e development of bleomycin-induced pulmonary fibrosis in rats. Lung Et -1 content doubled by 3 d following the intratracheal instillation of bleomycin, and continued to increase up to 7 d when values were about threefold greater than controls. Thereafter, the values for bleomycin- treated animals remained constant up to 21 d. There was no change in c ollagen content at 3 d but after 7 d there was a 25% increase and by 2 1 d levels were almost double those of the controls. In normal lung, E t-1 was predominantly associated with epithelial cells of conducting a nd nonconducting airways. Following bleomycin administration, intense staining of macrophages and conducting airway and alveolar epithelial cells was observed with marked staining of perivascular, peribronchiol ar, and alveolar septal connective tissue, as well as the venular and arterial intima and media. These results demonstrate elevation of Et-1 levels prior to an increase in collagen content which, along with its localization within developing fibrotic lesions, provides further evi dence of a profibrotic role for Et-1 in the pathogenesis of pulmonary fibrosis.